LastMonthinNeph

Thinking aloud on the recent evidence helping change the way our patients ‘feel-function-survive’. Account managed by @tukaramj @vkeskar @divyaa24 @drmjkulkarni

[LastMonthinNeph @LastNeph]

Is the jury out on the Ideal fluid for critically ill patients? Check out the latest edition of our blog where we discuss the PLUS trial and compare it with prior available evidence.
#LastMonthinNeph
https://t.co/YZfjMD1DV4

[LastMonthinNeph @LastNeph]

#lastmonthinneph Check out our new blog post! Malignant HTN: difficulties in management. Do you think RASi can be used in emergency management of HTN? Read on to find out! @tukaramj @vskeskar @divyaa24 @drmjkulkarni https://t.co/vwYgYea7Ma

[Manjunath Kulkarni 🇮🇳 @drmjkulkarni]

#lmin #lastmonthinneph check out our newblog post! this month we cover difficulties in managing Malignant Hypertension. https://t.co/rJc5jXzXr5 @LastNeph @tukaramj @divyaa24 @vskeskar

[LastMonthinNeph @LastNeph]

Check out this month's blog. Dawn of precision medicine in podocytopathy. Also understand how to detect a SPIN in a RCT. https://t.co/kab05rYiGu @tukaramj @vskeskar @arvindcanchi @hswapnil @nephromythri @MayuriTrivedi80 @anupamayj @SreejithDr @vjha126 @pradeepshenoy @drmjkulkarni

[tukaram @tukaramj]

A recent meta analysis in NEJM evidence concluded that HIF PHI are safe in both pre dialysis CKD and CKD5D. Before you take this conclusion to bedside, pause and go through the latest blogpost.

[LastMonthinNeph @LastNeph]

Check out latest blog post on safety of HIF PHI in anemia of CKD @tukaramj @vskeskar @divyaa24 @LastNeph @arvindcanchi @drprabhunephro @myadla @nephromythri

https://t.co/Upkdy9w1HI

[Manjunath Kulkarni 🇮🇳 @drmjkulkarni]

Can Hair straightening cause AKI? Can SGLT2 use put you in legal trouble? Do clinical practice guidelines reduce hospitalisation? What is new in GN management? Find out answers in our latest blog. @SreejithDr @pradeepshenoy @tukaramj @vskeskar @divyaa24 #lmin

[LastMonthinNeph @LastNeph]

@tukaramj @vskeskar @divyaa24

[LastMonthinNeph @LastNeph]

#lastmonthinneph #lmin check out latest blog. We cover impact of clinical practice guidelines, sparsentan in FSGS and IgAN, Sibeprenlimab in IgAN, Inaxapalin in APOL1 FSGS, False positive urine ethanol test and many more. https://t.co/vfRNu38s7F

[LastMonthinNeph @LastNeph]

@tukaramj @drmjkulkarni @vskeskar @divyaa24 @arvindcanchi @SreejithDr @pradeepkj79 #lastmonthinneph

[LastMonthinNeph @LastNeph]

Protein restriction in chronic kidney disease: our take on it. Please feel free to comment on our blog about your thoughts on protein restrictions https://t.co/0rWgarxc2m

[LastMonthinNeph @LastNeph]

@tukaramj @vskeskar @divyaa24 @drmjkulkarni #lastmonth #lmin

[LastMonthinNeph @LastNeph]

Check out latest blog . Hemodiafiltration vs hemodialysis. Are you CONVINCED?
Is Short course therapy for UTI in children better than the usual course ? https://t.co/GD0tdtAACv

[LastMonthinNeph @LastNeph]

#lmin HTN in CKD: what we know and what we don't know. See our blog in @LastNeph by @tukaramj @drmjkulkarni @vskeskar @divyaa24
https://t.co/XCaUK3VTXb

[LastMonthinNeph @LastNeph]

Check out May edition: thiazide battle, Renal denervation, Baxdrostat, Salt in HTN, Tailored BP therapy, Flozins in CKD, RAASi in progressive CKD @vskeskar @tukaramj @divyaa24 @drmjkulkarni
https://t.co/6XZNiJBepi

[LastMonthinNeph @LastNeph]

May 2023 https://t.co/6XZNiJAGzK

[Manjunath Kulkarni 🇮🇳 @drmjkulkarni]

“KDIGO 2021 Blood Pressure in CKD guideline” recommends a SBP target<120mm Hg in CKD(2B). Do you agree? @tukaramj @askrenal @vskeskar @divyaa24 @drprabhunephro @LastNeph @ASHWINSP1987 @AnandhUrmila @shankarmmcmed @nephromythri @anikethase @hswapnil

[LastMonthinNeph @LastNeph]

Latest coverage on ADVOR, DIAMOND, eGFR fallacy, IRGN, asymptomatic stone disease @tukaramj @divyaa24 @vskeskar @drmjkulkarni #lastmonthinnepph https://t.co/loxuCbKE1w

[LastMonthinNeph @LastNeph]

Check out our latest blog #lastmonthinneph https://t.co/loxuCbKE1w

[Int Society of Nephrology @ISNkidneycare]

𝗧𝗘𝗦𝗧 𝗬𝗢𝗨𝗥 𝗞𝗡𝗢𝗪𝗟𝗘𝗗𝗚𝗘 by taking the #ISNquiz "What do you know about Complement mediated Glomerulopathies?" developed by the @ISNeducation team members @divyaa24, @DrSumanBehera, @sibgokcay, and @Dilushiwijay.

🔗 https://t.co/yC7EIZZ1xC #NephTwitter #ISNyoung

[Dr. Divya Bajpai 🇮🇳 @divyaa24]

Under the able leadership of @tukaramj our dept is presenting 3 posters and 1 oral presentation at the #ISNFrontiers starting tomorrow in Delhi
On "infections and kidney diseases"
#nephforward